C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 09 12 2018
accepted: 23 04 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 22 8 2020
Statut: epublish

Résumé

C3 glomerulopathy (C3G) is a severe kidney disease, which is caused by defective regulation of the alternative complement pathway. Disease pathogenesis is heterogeneous and is caused by both autoimmune and genetic factors. Here we characterized IgG autoantibodies derived from 33 patients with autoimmune C3 glomerulopathy. Serum antibodies from all 33 patients as well as purified IgGs bound to the

Identifiants

pubmed: 31214159
doi: 10.3389/fimmu.2019.01030
pmc: PMC6554336
doi:

Substances chimiques

Antibodies, Monoclonal 0
Autoantibodies 0
Complement C3 0
Complement C5 0
Epitopes 0
Immunoglobulin G 0
Complement C3-C5 Convertases EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030

Références

Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72
pubmed: 1067618
J Exp Med. 1975 Oct 1;142(4):856-63
pubmed: 1185108
J Immunol. 1976 Jan;116(1):1-7
pubmed: 1245733
J Am Soc Nephrol. 2004 Mar;15(3):787-95
pubmed: 14978182
Kidney Int. 2006 Jul;70(1):42-50
pubmed: 16612335
Blood. 2008 Feb 1;111(3):1512-4
pubmed: 18006700
Nat Rev Nephrol. 2010 Aug;6(8):494-9
pubmed: 20606628
Lancet. 2010 Sep 4;376(9743):794-801
pubmed: 20800271
J Clin Invest. 2010 Oct;120(10):3702-12
pubmed: 20852386
Pediatr Nephrol. 2011 Mar;26(3):419-24
pubmed: 21188423
Genes Immun. 2011 Mar;12(2):90-9
pubmed: 21270828
Clin Immunol Immunopathol. 1990 Aug;56(2):226-38
pubmed: 2143128
Semin Nephrol. 2011 Jul;31(4):341-8
pubmed: 21839367
N Engl J Med. 2011 Dec 15;365(24):2340-2
pubmed: 22168663
N Engl J Med. 2012 Mar 22;366(12):1119-31
pubmed: 22435371
N Engl J Med. 2012 Mar 22;366(12):1161-3
pubmed: 22435382
Kidney Int. 2012 Aug;82(4):454-64
pubmed: 22456601
Am J Kidney Dis. 2012 Jul;60(1):121-5
pubmed: 22503529
J Am Soc Nephrol. 2012 Jul;23(7):1155-60
pubmed: 22626820
Kidney Int. 2012 Aug;82(4):465-73
pubmed: 22673887
Kidney Int. 2012 Aug;82(4):379-81
pubmed: 22846813
Nat Rev Nephrol. 2012 Nov;8(11):634-42
pubmed: 23026947
J Clin Invest. 2013 Jun;123(6):2434-46
pubmed: 23728178
Mol Immunol. 2013 Dec 15;56(3):213-21
pubmed: 23790637
J Clin Invest. 2014 Jan;124(1):145-55
pubmed: 24334459
Clin Immunol Immunopathol. 1989 Oct;53(1):113-22
pubmed: 2475285
Semin Thromb Hemost. 2014 Jun;40(4):472-7
pubmed: 24799307
Immunology. 1989 Dec;68(4):449-52
pubmed: 2481642
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82
pubmed: 25341722
Pediatr Nephrol. 2015 Feb;30(2):353-5
pubmed: 25395361
Mol Immunol. 2015 Sep;67(1):21-30
pubmed: 25929733
J Clin Immunol. 2016 Jul;36(5):517-27
pubmed: 27146825
Mol Immunol. 2016 Sep;77:89-96
pubmed: 27490940
Kidney Int. 2017 Nov;92(5):1232-1241
pubmed: 28712854
Kidney Int. 2017 Oct;92(4):876-887
pubmed: 28729035
Am J Kidney Dis. 2017 Dec;70(6):834-843
pubmed: 28838767
J Am Soc Nephrol. 2018 Jan;29(1):283-294
pubmed: 29030465
Am J Kidney Dis. 2018 Jul;72(1):84-92
pubmed: 29429752
Curr Opin Nephrol Hypertens. 2018 May;27(3):165-170
pubmed: 29517501
Pediatr Nephrol. 2019 Aug;34(8):1311-1323
pubmed: 29948306
Mayo Clin Proc. 2018 Aug;93(8):968-969
pubmed: 30077212
Front Immunol. 2018 Oct 15;9:2329
pubmed: 30487789
Clin Exp Immunol. 1986 Jul;65(1):73-9
pubmed: 3641694
Science. 1969 Apr 25;164(3878):436-7
pubmed: 4180576
J Exp Med. 1970 Jun 1;131(6):1306-24
pubmed: 4192571
Immunology. 1981 May;43(1):33-8
pubmed: 6166544
Clin Exp Immunol. 1983 Oct;54(1):253-8
pubmed: 6616970
J Clin Invest. 1980 Jun;65(6):1249-56
pubmed: 6902727
J Immunol Methods. 1982;51(1):101-7
pubmed: 6921216
J Biol Chem. 1997 Oct 3;272(40):25168-75
pubmed: 9312129
J Exp Med. 1976 Oct 1;144(4):1076-93
pubmed: 978134

Auteurs

Fei Zhao (F)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Sara Afonso (S)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Susanne Lindner (S)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Andrea Hartmann (A)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Ina Löschmann (I)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Bo Nilsson (B)

Department of Immunology, Genetics and Pathology, University Uppsala, Uppsala, Sweden.

Kristina N Ekdahl (KN)

Linneaus Center for Bomaterials Chemistry, Linnaeus University, Kalmar, Sweden.

Lutz T Weber (LT)

Children's and Adolescents' Hospital Cologne, University Hospital of Cologne, Cologne, Germany.

Sandra Habbig (S)

Children's and Adolescents' Hospital Cologne, University Hospital of Cologne, Cologne, Germany.

Gesa Schalk (G)

Children's and Adolescents' Hospital Cologne, University Hospital of Cologne, Cologne, Germany.

Michael Kirschfink (M)

Institute for Immunology, University Heidelberg, Heidelberg, Germany.

Peter F Zipfel (PF)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.
Faculty of Life Sciences, Friedrich Schiller University Jena, Jena, Germany.

Christine Skerka (C)

Deparment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH